A detailed history of Barclays PLC transactions in Pfizer Inc stock. As of the latest transaction made, Barclays PLC holds 15,242,809 shares of PFE stock, worth $419 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
15,242,809
Previous 21,565,306 29.32%
Holding current value
$419 Million
Previous $598 Million 28.73%
% of portfolio
0.13%
Previous 0.21%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $160 Million - $187 Million
-6,322,497 Reduced 29.32%
15,242,809 $426 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $257 Million - $296 Million
9,939,752 Added 85.5%
21,565,306 $598 Million
Q4 2023

Feb 15, 2024

SELL
$26.13 - $33.94 $118 Million - $153 Million
-4,503,233 Reduced 27.92%
11,625,554 $335 Million
Q3 2023

Nov 07, 2023

BUY
$32.09 - $37.51 $99.6 Million - $116 Million
3,102,892 Added 23.82%
16,128,787 $535 Million
Q2 2023

Aug 03, 2023

BUY
$36.12 - $41.79 $234 Million - $270 Million
6,466,670 Added 98.59%
13,025,895 $478 Million
Q1 2023

May 04, 2023

SELL
$39.39 - $51.28 $234 Million - $305 Million
-5,941,259 Reduced 47.53%
6,559,225 $268 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $138 Million - $180 Million
3,310,499 Added 36.02%
12,500,484 $641 Million
Q3 2022

Nov 03, 2022

BUY
$43.76 - $53.42 $87.2 Million - $106 Million
1,993,130 Added 27.69%
9,189,985 $402 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $192 Million - $228 Million
-4,125,023 Reduced 36.43%
7,196,855 $377 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $173 Million - $214 Million
-3,779,832 Reduced 25.03%
11,321,878 $586 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $23.7 Million - $35.2 Million
574,305 Added 3.95%
15,101,710 $892 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $175 Million - $225 Million
4,470,323 Added 44.45%
14,527,405 $625 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $52.4 Million - $59.4 Million
1,459,377 Added 16.97%
10,057,082 $394 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $15.5 Million - $17.5 Million
-463,591 Reduced 5.12%
8,597,705 $311 Million
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $174 Million - $222 Million
-5,206,772 Reduced 36.49%
9,061,296 $334 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $185 Million - $217 Million
5,833,187 Added 69.16%
14,268,068 $524 Million
Q2 2020

Aug 12, 2020

BUY
$30.12 - $36.54 $1.04 Million - $1.26 Million
34,450 Added 0.41%
8,434,881 $276 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $121 Million - $173 Million
-4,467,374 Reduced 34.72%
8,400,431 $274 Million
Q4 2019

Feb 10, 2020

SELL
$32.92 - $37.36 $2.75 Million - $3.12 Million
-83,392 Reduced 0.64%
12,867,805 $504 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $27.7 Million - $35.9 Million
-851,292 Reduced 6.17%
12,951,197 $465 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $32.2 Million - $36.2 Million
-870,915 Reduced 5.94%
13,802,489 $598 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $48.7 Million - $53.5 Million
1,299,086 Added 9.71%
14,673,404 $623 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $31.8 Million - $36.3 Million
-827,042 Reduced 5.82%
13,374,318 $584 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $7.04 Million - $8.55 Million
-204,377 Reduced 1.42%
14,201,360 $626 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $34.2 Million - $36.5 Million
1,038,492 Added 7.77%
14,405,737 $523 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $74.7 Million - $86.6 Million
2,340,112 Added 21.22%
13,367,245 $474 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $58.7 Million - $62.3 Million
1,765,138 Added 19.06%
11,027,133 $399 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $287 Million - $316 Million
9,261,995
9,261,995 $331 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.